224 related articles for article (PubMed ID: 27207443)
1. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.
Benchabane S; Boudjelida A; Toumi R; Belguendouz H; Youinou P; Touil-Boukoffa C
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):386-97. PubMed ID: 27207443
[TBL] [Abstract][Full Text] [Related]
2. Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sjögren's syndrome.
Benchabane S; Belguendouz H; Behairi N; Arroul-Lammali A; Boudjelida A; Youinou P; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):126-133. PubMed ID: 29303022
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
5. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
6. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
8. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Carcamo WC; Chiorini JA; Peck AB
Arthritis Res Ther; 2010; 12(6):R220. PubMed ID: 21182786
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
[TBL] [Abstract][Full Text] [Related]
11. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
Ciccia F; Alessandro R; Rodolico V; Guggino G; Raimondo S; Guarnotta C; Giardina A; Sireci G; Campisi G; De Leo G; Triolo G
Rheumatology (Oxford); 2013 Jun; 52(6):1009-17. PubMed ID: 23392590
[TBL] [Abstract][Full Text] [Related]
12. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
[TBL] [Abstract][Full Text] [Related]
15. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS
Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
[TBL] [Abstract][Full Text] [Related]
16. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjögren's syndrome).
Cejková J; Ardan T; Simonová Z; Cejka C; Malec J; Jirsová K; Filipec M; Dotrelová D; Brůnová B
Nitric Oxide; 2007 Aug; 17(1):10-7. PubMed ID: 17600738
[TBL] [Abstract][Full Text] [Related]
19. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
20. Expression of G
Sun Y; Wang Y; Chen S; Fan G; Zhang J; Dai F; Qian H; Liu Y; Shi G
J Immunol Res; 2018; 2018():8212641. PubMed ID: 29977933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
